Empirical Finance LLC purchased a new position in shares of Herbalife Ltd. (NYSE:HLF) during the 4th quarter, HoldingsChannel reports. The firm purchased 41,855 shares of the company’s stock, valued at approximately $2,834,000. Herbalife accounts for about 0.9% of Empirical Finance LLC’s holdings, making the stock its 18th largest holding.
Several other institutional investors and hedge funds have also made changes to their positions in HLF. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Herbalife by 36.5% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,445 shares of the company’s stock valued at $233,000 after buying an additional 922 shares during the last quarter. Opera Trading Capital grew its stake in Herbalife by 152.6% in the 4th quarter. Opera Trading Capital now owns 6,907 shares of the company’s stock valued at $468,000 after buying an additional 4,173 shares during the last quarter. APG Asset Management N.V. grew its stake in Herbalife by 640.9% in the 4th quarter. APG Asset Management N.V. now owns 353,400 shares of the company’s stock valued at $19,930,000 after buying an additional 305,700 shares during the last quarter. SG Americas Securities LLC grew its stake in Herbalife by 60.9% in the 4th quarter. SG Americas Securities LLC now owns 48,100 shares of the company’s stock valued at $3,257,000 after buying an additional 18,214 shares during the last quarter. Finally, State of Alaska Department of Revenue acquired a new position in Herbalife in the 4th quarter valued at $338,000.
Shares of Herbalife Ltd. (NYSE:HLF) traded up $1.07 during trading on Thursday, reaching $84.06. 1,237,258 shares of the company’s stock were exchanged, compared to its average volume of 976,865. The company has a current ratio of 2.65, a quick ratio of 2.24 and a debt-to-equity ratio of 9.94. Herbalife Ltd. has a 12-month low of $50.70 and a 12-month high of $84.96. The company has a market cap of $7,233.01, a P/E ratio of 19.10 and a beta of 1.25.
Herbalife (NYSE:HLF) last issued its quarterly earnings results on Thursday, November 2nd. The company reported $0.82 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.82. Herbalife had a net margin of 8.60% and a return on equity of 176.64%. The firm had revenue of $1.09 billion during the quarter, compared to the consensus estimate of $1.09 billion. During the same period in the prior year, the firm earned $1.21 EPS. The business’s revenue was down 3.3% on a year-over-year basis. analysts forecast that Herbalife Ltd. will post 4.55 earnings per share for the current year.
In other Herbalife news, SVP Thomas Harms sold 8,532 shares of the stock in a transaction on Friday, December 29th. The shares were sold at an average price of $68.49, for a total value of $584,356.68. Following the completion of the sale, the senior vice president now directly owns 1,000 shares of the company’s stock, valued at approximately $68,490. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Robert Levy sold 6,980 shares of the stock in a transaction on Friday, January 26th. The shares were sold at an average price of $78.54, for a total transaction of $548,209.20. Following the completion of the sale, the executive vice president now directly owns 212,595 shares of the company’s stock, valued at $16,697,211.30. The disclosure for this sale can be found here. Over the last three months, insiders sold 38,201 shares of company stock valued at $2,801,087. Insiders own 4.95% of the company’s stock.
A number of research analysts recently issued reports on the stock. Pivotal Research reiterated a “buy” rating and issued a $120.00 target price on shares of Herbalife in a research note on Thursday, January 25th. Zacks Investment Research lowered shares of Herbalife from a “buy” rating to a “hold” rating in a research note on Wednesday, October 4th. ValuEngine lowered shares of Herbalife from a “strong-buy” rating to a “buy” rating in a research note on Monday, December 4th. Finally, SunTrust Banks reiterated a “hold” rating and issued a $67.00 target price on shares of Herbalife in a research note on Friday, November 10th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Herbalife presently has an average rating of “Hold” and an average target price of $83.25.
ILLEGAL ACTIVITY NOTICE: “41,855 Shares in Herbalife Ltd. (HLF) Acquired by Empirical Finance LLC” was published by Transcript Daily and is the property of of Transcript Daily. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark and copyright legislation. The legal version of this piece can be viewed at https://transcriptdaily.com/2018/02/01/41855-shares-in-herbalife-ltd-hlf-acquired-by-empirical-finance-llc.html.
Herbalife Ltd. is a global nutrition company. The Company develops and sells weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, as well as personal care products. Its operating segments are based on geographical operations in six regions: North America; Mexico; South and Central America; Europe, the Middle East, and Africa (EMEA); Asia Pacific, and China.
Want to see what other hedge funds are holding HLF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Herbalife Ltd. (NYSE:HLF).
Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.